Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 6/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.43 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11007366 | 0.87 | ADRB2 (0.47) | ADRB2ADRB1LTB4RLTB4R2HTT | |
| SCHEMBL11433407 | 0.87 | ADRB2 (0.47) | ADRB2ADRB1LTB4RLTB4R2HTT | |
| SCHEMBL7185822 | 0.85 | ADRB2 (0.49) | ADRB2ADRB1LTB4RLTB4R2HTT | |
| SCHEMBL10626121 | 0.83 | THRB (0.54) | LTB4RLTB4R2HTTMAPTL3MBTL1 | |
| SCHEMBL10629984 | 0.83 | THRB (0.54) | LTB4RLTB4R2HTTMAPTL3MBTL1 | |
| SCHEMBL8521939 | 0.83 | THRB (0.54) | LTB4RLTB4R2HTTMAPTL3MBTL1 | |
| SCHEMBL30863 | 0.83 | THRB (0.54) | LTB4RLTB4R2HTTMAPTL3MBTL1 | |
| SCHEMBL10625676 | 0.83 | THRB (0.54) | LTB4RLTB4R2HTTMAPTL3MBTL1 | |
| SCHEMBL170614 | 0.83 | THRB (0.54) | LTB4RLTB4R2HTTMAPTL3MBTL1 | |
| SCHEMBL7582728 | 0.83 | THRB (0.54) | LTB4RLTB4R2HTTMAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200017655-A1 | POROUS CROSSLINKED HYDROPHILIC POLYMERIC MATERIALS PREPARED FROM HIGH INTERNAL PHASE EMULSIONS CONTAINING HYDROPHILIC POLYMERS | LI NAIHONG (US) | 2020-01-16 | — | — | US | claimed |
| WO-2018161155-A1 | POROUS CROSSLINKED HYDROPHILIC POLYMERIC MATERIALS PREPARED FROM HIGH INTERNAL PHASE EMULSIONS CONTAINING HYDROPHILIC POLYMERS | MOASIS INC. (US) | 2018-09-13 | — | — | WO | claimed |
| US-20160120946-A1 | COMPOSITIONS COMPRISING GC-MACROPHAGE ACTIVATING FACTOR AND USES THEREOF | EFRANAT LTD. (IL) | 2016-05-05 | — | — | US | claimed |
| EP-3007720-A1 | COMPOSITIONS COMPRISING GC- MACROPHAGE ACTIVATING FACTOR AND USES THEREOF | Efranat Ltd. (IL) | 2016-04-20 | — | — | EP | claimed |
| WO-2014199373-A1 | COMPOSITIONS COMPRISING GC- MACROPHAGE ACTIVATING FACTOR AND USES THEREOF | EFRANAT LTD. (IL) | 2014-12-18 | — | — | WO | claimed |
| US-8173166-B2 | Methods of producing tungsten nanoparticles | HONDA MOTOR CO., LTD. (JP) | 2012-05-08 | — | — | US | claimed |
| US-20080044807-A1 | Method of Detecting Hepatitis C Virus | ADVANCED LIFE SCIENCE INSTITUTE, INC. (JP) | 2008-02-21 | — | — | US | claimed |
| EP-1365731-B1 | A CONTROLLED DELIVERY SYSTEM FOR HAIR CARE PRODUCTS | SALVONA LLC (US) | 2008-01-02 | — | — | EP | claimed |
| EP-1365731-A4 | A CONTROLLED DELIVERY SYSTEM FOR HAIR CARE PRODUCTS | SALVONA LLC (US) | 2007-03-21 | — | — | EP | claimed |
| WO-2007030254-A2 | METHODS OF PRODUCING TUNGSTEN NANOPARTICLES | HONDA MOTOR CO., LTD. (JP) | 2007-03-15 | — | — | WO | claimed |
| EP-1691198-A1 | METHOD OF DETECTING HEPATITIS C VIRUS | Advanced Life Science Institute, Inc. (JP) | 2006-08-16 | — | — | EP | claimed |
| EP-1328257-A4 | BIODEGRADABLE BIOADHESIVE CONTROLLED RELEASE SYSTEM OF NANO-PARTICLES FOR ORAL CARE PRODUCTS | SALVONA LLC (US) | 2004-10-13 | — | — | EP | claimed |
| EP-1365731-A1 | A CONTROLLED DELIVERY SYSTEM FOR HAIR CARE PRODUCTS | Salvona L.L.C. (US) | 2003-12-03 | — | — | EP | claimed |
| US-20030147956-A1 | Biodegradable bioadhesive controlled release system of nano-particles for oral care products | SALVONA LLC | 2003-08-07 | — | — | US | claimed |
| EP-1328257-A2 | BIODEGRADABLE BIOADHESIVE CONTROLLED RELEASE SYSTEM OF NANO-PARTICLES FOR ORAL CARE PRODUCTS | Salvona L.L.C. (US) | 2003-07-23 | — | — | EP | claimed |
| US-6565873-B1 | Nanoparticles containing hydrophobic core; heating, dispersing, mixing, cooling | SALVONA LLC | 2003-05-20 | — | — | US | claimed |
| US-6491902-B2 | FOR USE IN SHAMPOO, CONDITIONERS AND HAIR STYLING PRODUCTS | SALVONA LLC | 2002-12-10 | — | — | US | claimed |
| US-20020146379-A1 | CONTROLLED DELIVERY SYSTEM FOR HAIR CARE PRODUCTS | SALVONA LLC | 2002-10-10 | — | — | US | claimed |
| WO-2002060399-A1 | A CONTROLLED DELIVERY SYSTEM FOR HAIR CARE PRODUCTS | SALVONA LLC (US) | 2002-08-08 | — | — | WO | claimed |
| WO-2002041765-A2 | BIODEGRADABLE BIOADHESIVE CONTROLLED RELEASE SYSTEM OF NANO-PARTICLES FOR ORAL CARE PRODUCTS | SALVONA L.L.C. (US) | 2002-05-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020146379-A1 | CONTROLLED DELIVERY SYSTEM FOR HAIR CARE PRODUCTS | TRPC5, CATSPER1, TRPV1 | ADRB2 2221/4885ADRB1 2475/4885LTB4R 3483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.